These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 28968425)
21. Canonical NF-κB signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded protein response. Sunami Y; Ringelhan M; Kokai E; Lu M; O'Connor T; Lorentzen A; Weber A; Rodewald AK; Müllhaupt B; Terracciano L; Gul S; Wissel S; Leithäuser F; Krappmann D; Riedl P; Hartmann D; Schirmbeck R; Strnad P; Hüser N; Kleeff J; Friess H; Schmid RM; Geisler F; Wirth T; Heikenwalder M Hepatology; 2016 May; 63(5):1592-607. PubMed ID: 26892811 [TBL] [Abstract][Full Text] [Related]
22. Anti-platelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma. Sitia G; Iannacone M; Guidotti LG J Hepatol; 2013 Nov; 59(5):1135-8. PubMed ID: 23742914 [TBL] [Abstract][Full Text] [Related]
23. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter]. Zhu R; Li BZ; Ling YQ; Zhang HP; Li H; Liu Y; Hu XQ; Zhu HG Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):166-70. PubMed ID: 17649629 [TBL] [Abstract][Full Text] [Related]
24. Coexpression network analysis in chronic hepatitis B and C hepatic lesions reveals distinct patterns of disease progression to hepatocellular carcinoma. He D; Liu ZP; Honda M; Kaneko S; Chen L J Mol Cell Biol; 2012 Jun; 4(3):140-52. PubMed ID: 22467683 [TBL] [Abstract][Full Text] [Related]
25. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression. Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183 [TBL] [Abstract][Full Text] [Related]
26. Association of p16INK4A hypermethylation with hepatitis B virus X protein expression in the early stage of HBV-associated hepatocarcinogenesis. Zhu R; Li BZ; Li H; Ling YQ; Hu XQ; Zhai WR; Zhu HG Pathol Int; 2007 Jun; 57(6):328-36. PubMed ID: 17539963 [TBL] [Abstract][Full Text] [Related]
27. Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling. Ueda T; Honda M; Horimoto K; Aburatani S; Saito S; Yamashita T; Sakai Y; Nakamura M; Takatori H; Sunagozaka H; Kaneko S Genomics; 2013 Apr; 101(4):238-48. PubMed ID: 23485556 [TBL] [Abstract][Full Text] [Related]
28. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias. Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697 [TBL] [Abstract][Full Text] [Related]
29. Early molecular and genetic determinants of primary liver malignancy. Feitelson MA; Pan J; Lian Z Surg Clin North Am; 2004 Apr; 84(2):339-54. PubMed ID: 15062649 [TBL] [Abstract][Full Text] [Related]
30. Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin. Yu MC; Lee YS; Lin SE; Wu HY; Chen TC; Lee WC; Chen MF; Tsai CN Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S455-63. PubMed ID: 21822558 [TBL] [Abstract][Full Text] [Related]
31. The transcription factor c-JUN/AP-1 promotes HBV-related liver tumorigenesis in mice. Trierweiler C; Hockenjos B; Zatloukal K; Thimme R; Blum HE; Wagner EF; Hasselblatt P Cell Death Differ; 2016 Apr; 23(4):576-82. PubMed ID: 26470729 [TBL] [Abstract][Full Text] [Related]
32. Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B. Sitia G; Aiolfi R; Di Lucia P; Mainetti M; Fiocchi A; Mingozzi F; Esposito A; Ruggeri ZM; Chisari FV; Iannacone M; Guidotti LG Proc Natl Acad Sci U S A; 2012 Aug; 109(32):E2165-72. PubMed ID: 22753481 [TBL] [Abstract][Full Text] [Related]
33. Different expression of hepatitis B surface antigen between hepatocellular carcinoma and its surrounding liver tissue, studied using a tissue microarray. Wang Y; Wu MC; Sham JS; Tai LS; Fang Y; Wu WQ; Xie D; Guan XY J Pathol; 2002 Aug; 197(5):610-6. PubMed ID: 12210080 [TBL] [Abstract][Full Text] [Related]
34. Tissue microarray for high-throughput analysis of gene expression profiles in hepatocellular carcinoma. Liu K; Lei XZ; Zhao LS; Tang H; Liu L; Feng P; Lei BJ World J Gastroenterol; 2005 Mar; 11(9):1369-72. PubMed ID: 15761978 [TBL] [Abstract][Full Text] [Related]
35. Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma. Nishida N; Nagasaka T; Nishimura T; Ikai I; Boland CR; Goel A Hepatology; 2008 Mar; 47(3):908-18. PubMed ID: 18161048 [TBL] [Abstract][Full Text] [Related]
36. Gene expression analysis in HBV transgenic mouse liver: a model to study early events related to hepatocarcinogenesis. Barone M; Spano D; D'Apolito M; Centra M; Lasalandra C; Capasso M; Di Leo A; Volinia S; Arcelli D; Rosso N; Francavilla A; Tiribelli C; Iolascon A Mol Med; 2006; 12(4-6):115-23. PubMed ID: 16953557 [TBL] [Abstract][Full Text] [Related]
37. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma. Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206 [TBL] [Abstract][Full Text] [Related]
38. [Identification of hepatitis B virus integration sites in hepatocellular carcinoma tissues from patients with chronic hepatitis B]. Tu H; Gao HF; Ma GH; Liu Y Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1249-52. PubMed ID: 16796883 [TBL] [Abstract][Full Text] [Related]
39. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B. Murata M; Matsuzaki K; Yoshida K; Sekimoto G; Tahashi Y; Mori S; Uemura Y; Sakaida N; Fujisawa J; Seki T; Kobayashi K; Yokote K; Koike K; Okazaki K Hepatology; 2009 Apr; 49(4):1203-17. PubMed ID: 19263472 [TBL] [Abstract][Full Text] [Related]
40. Increased ERp57 Expression in HBV-Related Hepatocellular Carcinoma: Possible Correlation and Prognosis. Liu M; Du L; He Z; Yan L; Shi Y; Shang J; Tang H Biomed Res Int; 2017; 2017():1252647. PubMed ID: 28373975 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]